Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0613820230330080663
Journal of Life Science
2023 Volume.33 No. 8 p.663 ~ p.679
ÅؽºÆ® ¸¶ÀÌ´×À» ÀÌ¿ëÇÑ ÀΰøÁö´É È°¿ë ½Å¾à °³¹ß ¿¬±¸ µ¿Ç⠺м®
Nam Jae-Woo

Kim Young-Jun
Abstract
This review analyzes research trends related to new drug development using artificial intelligence from 2010 to 2022. This analysis organized the abstracts of 2,421 studies into a corpus, and words with high frequency and high connection centrality were extracted through preprocessing. The analysis revealed a similar word frequency trend between 2010 and 2019 to that between 2020 and 2022. In terms of the research method, many studies using machine learning were conducted from 2010 to 2020, and since 2021, research using deep learning has been increasing. Through these studies, we investigated the trends in research on artificial intelligence utilization by field and the strengths, problems, and challenges of related research. We found that since 2021, the application of artificial intelligence has been expanding, such as research using artificial intelligence for drug rearrangement, using computers to develop anticancer drugs, and applying artificial intelligence to clinical trials. This article briefly presents the prospects of new drug development research using artificial intelligence. If the reliability and safety of bio and medical data are ensured, and the development of the above artificial intelligence technology continues, it is judged that the direction of new drug development using artificial intelligence will proceed to personalized medicine and precision medicine, so we encourage efforts in that field.
KEYWORD
AI, deep learning, machine learning, new drug development, text mining
FullTexts / Linksout information
Listed journal information